BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 31

• Business

  Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results

  Protalix BioTherapeutics, Inc. reported financial results for the fiscal year ended December 31, 2023, and provided a business update.

  March 14, 2024

   · 

  18 min read
• Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing

  Pluri Inc. announced that its CDMO division has signed a manufacturing agreement with Remedy Cell Ltd, an innovative, biopharmaceutical company developing stem cell-derived, cell-free therapeutics for complex fibrotic conditions.

  March 14, 2024

   · 

  5 min read
• Biotech Beach

  PreludeDx™ Announces Novel Test for Predicting Radiation Therapy Benefit and Recurrence Risk in Early-Stage Invasive Breast Cancer Patients

  Prelude Corporation has unveiled data from an analysis of over 700 early-stage invasive breast cancer patients for AidaBreast.

  March 14, 2024

   · 

  5 min read
• Business

  Exscientia to Report Full Year 2023 Financial Results on March 21, 2024

  Company to host conference call and webcast on March 21, 2024, at 12:30 p.m. GMT / 8:30 a.m. EDT.

  March 14, 2024

   · 

  1 min read
• Business

  Benson Hill Reports Solid Full-Year 2023 Financial Results, Strengthens Balance Sheet

  Benson Hill, Inc. (NYSE:BHIL, the “Company” or “Benson Hill”), an ag-tech company unlocking the natural genetic diversity of plants, today announced operating and financial results for the year ended December 31, 2023.

  March 14, 2024

   · 

  25 min read
• Biotech Bay

  GeminiBio’s Aseptic Assurance System™ Supports Closed System Manufacturing for Cell Therapies

  Gemini Bioproducts, LLC today announced the launch of new products designed to improve cell therapy manufacturing processes.

  March 14, 2024

   · 

  3 min read
• BioCapital

  Noramco Announces Strategic Alignment with Purisys and Halo Pharma, Launching the Noramco Group as an Integrated North American-Based API and Drug Product Supply Chain Services Provider

  Noramco announced its launch of the Noramco Group, a newly created comprehensive North American-based supply chain solution including subsidiaries Purisys, Noramco, and the newly acquired drug product CDMO, Halo Pharma.

  March 14, 2024

   · 

  6 min read
• Business

  Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates

  Century Therapeutics, Inc. today reported financial results and business highlights for the full year ended December 31, 2023.

  March 14, 2024

   · 

  14 min read
• Drug Development

  Cybin Announces Positive End-of-Phase 2 Meeting with FDA for CYB003 in Major Depressive Disorder and Phase 3 Program Design

  Cybin Inc. today announced a positive End-of-Phase 2 meeting with the FDA for CYB003, its deuterated psilocybin analog for the adjunctive treatment of Major Depressive Disorder (“MDD”).

  March 14, 2024

   · 

  10 min read
• Business

  Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024

  Achieve Life Sciences, Inc. today announced it will report its fourth quarter and year-end 2023 financial results and provide an update on the cytisinicline development program on Thursday, March 28, 2024, at 4:30 PM EST.

  March 14, 2024

   · 

  4 min read